Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation

Florence WJ Chioh, Siew-Wai Fong, Barnaby E. Young, Kan-Xing Wu, Anthony Siau, Shuba Krishnan, Yi-Hao Chan, Louis LY Teo, Fei Gao, Ru San Tan, Liang Zhong, Angela S. Koh, Seow-Yen Tan, Paul A. Tambyah, Laurent Renia, Lisa FP Ng, David C Lye, View ORCID ProfileChristine Cheung
doi: https://doi.org/10.1101/2020.11.16.20232835
Florence WJ Chioh
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siew-Wai Fong
5A*STAR ID Labs, Agency for Science, Technology and Research, Singapore
6Singapore Immunology Network, Agency for Science, Technology and Research, Singapore
10Department of Biological Sciences, National University of Singapore, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barnaby E. Young
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
3National Centre for Infectious Diseases, Singapore
4Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kan-Xing Wu
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Siau
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuba Krishnan
11Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi-Hao Chan
5A*STAR ID Labs, Agency for Science, Technology and Research, Singapore
6Singapore Immunology Network, Agency for Science, Technology and Research, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis LY Teo
8National Heart Centre Singapore, Singapore
9Duke-NUS Medical School, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Gao
8National Heart Centre Singapore, Singapore
9Duke-NUS Medical School, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ru San Tan
8National Heart Centre Singapore, Singapore
9Duke-NUS Medical School, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liang Zhong
8National Heart Centre Singapore, Singapore
9Duke-NUS Medical School, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela S. Koh
8National Heart Centre Singapore, Singapore
9Duke-NUS Medical School, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seow-Yen Tan
13Department of Infectious Diseases, Changi General Hospital, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. Tambyah
3National Centre for Infectious Diseases, Singapore
14Department of Medicine, National University Hospital, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Renia
5A*STAR ID Labs, Agency for Science, Technology and Research, Singapore
6Singapore Immunology Network, Agency for Science, Technology and Research, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa FP Ng
5A*STAR ID Labs, Agency for Science, Technology and Research, Singapore
6Singapore Immunology Network, Agency for Science, Technology and Research, Singapore
12Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C Lye
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
3National Centre for Infectious Diseases, Singapore
4Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore
7Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Cheung
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
2Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christine Cheung
  • For correspondence: ccheung@ntu.edu.sg
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The rapid rise of coronavirus disease 2019 patients who suffer from vascular events after their initial recovery is expected to lead to a worldwide shift in disease burden. We aim to investigate the impact of COVID-19 on the pathophysiological state of blood vessels in convalescent patients. Here, convalescent COVID-19 patients with or without preexisting conditions (i.e. hypertension, diabetes, hyperlipidemia) were compared to non-COVID-19 patients with matched cardiovascular risk factors or healthy participants. Convalescent patients had elevated circulating endothelial cells (CECs), and those with underlying cardiovascular risk had more pronounced endothelial activation hallmarks (ICAM1, P-selectin or CX3CL1) expressed by CECs. Multiplex microbead-based immunoassays revealed some levels of cytokine production sustained from acute infection to recovery phase. Several proinflammatory and activated T lymphocyte-associated cytokines correlated positively with CEC measures, implicating cytokine-driven endothelial dysfunction. Finally, the activation markers detected on CECs mapped to the counter receptors (i.e. ITGAL, SELPLG, and CX3CR1) found primarily on CD8+ T cells and natural killer cells, suggesting that activated endothelial cells could be targeted by cytotoxic effector cells. Clinical trials in preventive therapy for post-COVID-19 vascular complications may be needed.

Figure
  • Download figure
  • Open in new tab

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the National Medical Research Council COVID-19 Research Fund (COVID19RF-001 and COVID19RF-060) and COVID-19 (project number H20/04/g1/006) research grants provided to Singapore Immunology Network (SIgN) by the Biomedical Research Council (BMRC), A*STAR. The SIgN flow cytometry, Multiple analyte platforms and Immunomonitoring Service Platform (ISP) were supported a grant (#NRF2017_SISFP09) from the National Research Foundation (NRF), Singapore. The team from Nanyang Technological University Singapore was funded by the Nanyang Assistant Professorship, Academic Research Fund grant (MOE2018-T2-1-042) from the Ministry of Education, Singapore, and an Industrial Alignment Fund Pre-Positioning grant (H18/01/a0/017) from Agency for Science, Technology and Research, Singapore. The team from National Heart Centre Singapore was supported by the National Medical Research Council of Singapore (NMRC/TA/0031/2015, MOH-000153, NMRC/OFIRG/0018/2016, NMRC/BnB/0017/2015, MOH-000358).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Local Ethics Committee of the National Healthcare Group (2012/00917) and Nanyang Technological University Singapore Institutional Review Board (IRB-2020-09-011).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are available as they are reported in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
Florence WJ Chioh, Siew-Wai Fong, Barnaby E. Young, Kan-Xing Wu, Anthony Siau, Shuba Krishnan, Yi-Hao Chan, Louis LY Teo, Fei Gao, Ru San Tan, Liang Zhong, Angela S. Koh, Seow-Yen Tan, Paul A. Tambyah, Laurent Renia, Lisa FP Ng, David C Lye, Christine Cheung
medRxiv 2020.11.16.20232835; doi: https://doi.org/10.1101/2020.11.16.20232835
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
Florence WJ Chioh, Siew-Wai Fong, Barnaby E. Young, Kan-Xing Wu, Anthony Siau, Shuba Krishnan, Yi-Hao Chan, Louis LY Teo, Fei Gao, Ru San Tan, Liang Zhong, Angela S. Koh, Seow-Yen Tan, Paul A. Tambyah, Laurent Renia, Lisa FP Ng, David C Lye, Christine Cheung
medRxiv 2020.11.16.20232835; doi: https://doi.org/10.1101/2020.11.16.20232835

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (553)
  • Anesthesia (135)
  • Cardiovascular Medicine (1761)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (660)
  • Epidemiology (10803)
  • Forensic Medicine (8)
  • Gastroenterology (593)
  • Genetic and Genomic Medicine (2953)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1930)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (631)
  • Infectious Diseases (except HIV/AIDS) (12520)
  • Intensive Care and Critical Care Medicine (693)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2801)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1469)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (867)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2641)
  • Public and Global Health (5374)
  • Radiology and Imaging (1014)
  • Rehabilitation Medicine and Physical Therapy (596)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (126)